Compensatory Cognitive Rehabilitation for Mild Cognitive Impairment

"This clinical trial aims to measure shifts in Memory Based Compensation over a pre- and post-treatment timeframe. Secondary objectives include evaluating changes in Self Efficacy, Quality of Life, and Maintained Changes in Memory Based Everyday Function through the use of the Memory Loss Self Efficacy Scale (9 items rated on 10 point scales from 1 - not at all confident to 10 - fully confident), QOL-AD questionnaire (13 items assessed with 4 point rating scale) as well as ECog Questionnaire (39 items measured with a four-point score system ranging from 1: better or no change; 4: consistently much worse)."

"This trial is open to seniors ages 60-90."

"This research project requires 65 subjects diagnosed with Alzheimer's disease between the ages of 60-90. The following are necessary prerequisites for consideration: elderly age range, command of English language, functional eyesight and hearing to complete phone screen, no recent use or stabilization (2+ months) on cognitive enhancing medications, and amnestic mild cognitive impairment from probable Alzheimer's disorder."

"Our team has assigned a score of 1 to Structured External Memory Aid Treatment (SEMAT), indicating that there is only limited data available on the safety and efficacy this treatment."

"Affirmative. Information on clinicaltrials.gov reveals that this experiment is still in the process of acquiring participants, with 65 participants needed from a single medical facility. This project was initially uploaded to their database on January 5th 2022 and most recently updated 19th May 2022."

"As per the information displayed on clinicaltrials.gov, this particular medical research is currently seeking people to participate in the trial. It was first made public on January 5th 2022 and last revised on May 19th of that same year."